Case Study: Scientists' perspectives on the challenges of cell and gene therapy
20 March 2024

Cell and gene therapy, particularly gene editing, holds significant promise, specialists believe. Artificial intelligence (AI) is also identified as a key player, yet adoption remains low, suggesting a need for technology integration. Explore the differing views of the scientific community towards cell and gene therapy in this case study from SelectScience®. Hear from those who feel critical challenges need addressing, as well as the long-term efficacy, scalability of testing and manufacturing processes, and product generation. Furthermore, dealing with regulatory and ethical concerns surrounding cell and gene therapy is deemed particularly challenging, likely due to the field's novelty.